SAN DIEGO, March 21, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced that it will report its results for the fourth quarter and year-end 2013 on Monday, March 31, 2014. The company will also hold a live investor conference call and webcast at 4:30pm Eastern/1:30pm Pacific on Monday, March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
